Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

Julia H. Arnsten, Penelope A. Demas, Richard W. Grant, Marc N. Gourevitch, Homayoon Farzadegan, Andrea A. Howard, Ellie Schoenbaum

Research output: Contribution to journalArticle

388 Citations (Scopus)

Abstract

Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

Original languageEnglish (US)
Pages (from-to)377-381
Number of pages5
JournalJournal of General Internal Medicine
Volume17
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Drug Users
Cocaine
HIV
Pharmaceutical Preparations
Therapeutics
Depression
Social Security
Psychological Adaptation
Alcohols

Keywords

  • Adherence
  • Antiretroviral therapy
  • Drug users
  • Electronic monitors

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. / Arnsten, Julia H.; Demas, Penelope A.; Grant, Richard W.; Gourevitch, Marc N.; Farzadegan, Homayoon; Howard, Andrea A.; Schoenbaum, Ellie.

In: Journal of General Internal Medicine, Vol. 17, No. 5, 2002, p. 377-381.

Research output: Contribution to journalArticle

Arnsten, Julia H. ; Demas, Penelope A. ; Grant, Richard W. ; Gourevitch, Marc N. ; Farzadegan, Homayoon ; Howard, Andrea A. ; Schoenbaum, Ellie. / Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. In: Journal of General Internal Medicine. 2002 ; Vol. 17, No. 5. pp. 377-381.
@article{a113fd4f21154e5286cf87ef6b90b875,
title = "Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users",
abstract = "Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27{\%}, compared to 68{\%} among subjects who reported no cocaine use during the 6-month study period. Consequently, 13{\%} of active cocaine users maintained viral suppression, compared to 46{\%} of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.",
keywords = "Adherence, Antiretroviral therapy, Drug users, Electronic monitors",
author = "Arnsten, {Julia H.} and Demas, {Penelope A.} and Grant, {Richard W.} and Gourevitch, {Marc N.} and Homayoon Farzadegan and Howard, {Andrea A.} and Ellie Schoenbaum",
year = "2002",
doi = "10.1046/j.1525-1497.2002.10644.x",
language = "English (US)",
volume = "17",
pages = "377--381",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

AU - Arnsten, Julia H.

AU - Demas, Penelope A.

AU - Grant, Richard W.

AU - Gourevitch, Marc N.

AU - Farzadegan, Homayoon

AU - Howard, Andrea A.

AU - Schoenbaum, Ellie

PY - 2002

Y1 - 2002

N2 - Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

AB - Despite a burgeoning literature on adherence to HIV therapies, few studies have examined the impact of ongoing drug use on adherence and viral suppression, and none of these have utilized electronic monitors to quantify adherence among drug users. We used 262 electronic monitors to measure adherence with all antiretrovirals in 85 HIV-infected current and former drug users, and found that active cocaine use, female gender, not receiving Social Security benefits, not being married, screening positive for depression, and the tendency to use alcohol or drugs to cope with stress were all significantly associated with poor adherence. The strongest predictor of poor adherence and, in turn, failure to maintain viral suppression, was active cocaine use. Overall adherence among active cocaine users was 27%, compared to 68% among subjects who reported no cocaine use during the 6-month study period. Consequently, 13% of active cocaine users maintained viral suppression, compared to 46% of nonusers. Interventions to improve adherence should focus on reducing cocaine use, developing adaptive coping skills, and identifying and treating depression.

KW - Adherence

KW - Antiretroviral therapy

KW - Drug users

KW - Electronic monitors

UR - http://www.scopus.com/inward/record.url?scp=0036282710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036282710&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1497.2002.10644.x

DO - 10.1046/j.1525-1497.2002.10644.x

M3 - Article

C2 - 12047736

AN - SCOPUS:0036282710

VL - 17

SP - 377

EP - 381

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 5

ER -